Cargando…

Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis

To increase the effectiveness of anticancer therapy based on immune checkpoint (IC) inhibition, some ICs are being investigated in addition to those used in clinic. We reviewed data on the relationship between PD-L1, B7-H3, B7-H4, IDO1, Galectin-3 and -9, CEACAM1, CD155, Siglec-15 and ADAM17 express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansorunov, Danzan, Apanovich, Natalya, Apanovich, Pavel, Kipkeeva, Fatimat, Muzaffarova, Tatyana, Kuzevanova, Anna, Nikulin, Maxim, Malikhova, Olga, Karpukhin, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700640/ https://www.ncbi.nlm.nih.gov/pubmed/34943606 http://dx.doi.org/10.3390/diagnostics11122370

Ejemplares similares

The Correlation of Ten Immune Checkpoint Gene Expressions and Their Association with Gastric Cancer Development
por: Mansorunov, Danzan, et al.
Publicado: (2022)

The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
por: Kipkeeva, Fatimat, et al.
Publicado: (2022)

MicroRNA in Gastric Cancer Development: Mechanisms and Biomarkers
por: Kipkeeva, Fatimat, et al.
Publicado: (2020)

The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
por: Kuzevanova, Anna, et al.
Publicado: (2022)

The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer
por: Apanovich, Natalya, et al.
Publicado: (2021)

MiRNA Expression in Neuroendocrine Neoplasms of Frequent Localizations
por: Korotaeva, Alexandra, et al.
Publicado: (2021)

The Genes—Candidates for Prognostic Markers of Metastasis by Expression Level in Clear Cell Renal Cell Cancer
por: Apanovich, Natalya, et al.
Publicado: (2020)

Prediction of Distant Metastases in Patients with Kidney Cancer Based on Gene Expression and Methylation Analysis
por: Apanovich, Natalya, et al.
Publicado: (2023)

Analytic and Holistic Thinkers: Differences in the Dynamics of Heart Rate Complexity When Solving a Cognitive Task in Field-Dependent and Field-Independent Conditions
por: Bakhchina, Anastasiia V., et al.
Publicado: (2021)

Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases
por: Loginov, Vitaly I., et al.
Publicado: (2022)

Reaction to norm transgressions and Islamization threat in culturally tight and loose contexts: a cross-cultural comparison of Germany versus Russia
por: Prentice, Liza, et al.
Publicado: (2018)

An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor
por: Deng, Guiming, et al.
Publicado: (2023)

Biomarkers to predict prognosis and response to checkpoint inhibitors
por: Yuasa, Takeshi, et al.
Publicado: (2017)

Luminal and Tumor-Associated Gut Microbiome Features Linked to Precancerous Lesions Malignancy Risk: A Compositional Approach
por: Romanov, Vladimir A., et al.
Publicado: (2022)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma
por: Tsai, Chung-Ying, et al.
Publicado: (2021)

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor‐associated cardiotoxicity
por: Liang, Lin, et al.
Publicado: (2023)

Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer
por: Zhen, Zili, et al.
Publicado: (2022)

Pleural fluid microbiota as a biomarker for malignancy and prognosis
por: Kwok, Benjamin, et al.
Publicado: (2023)

Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation
por: Yin, Xin, et al.
Publicado: (2022)

GRK3 as a Prognosis Biomarker in Gastric Cancer
por: Fang, Chia-Lang, et al.
Publicado: (2022)

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2022)

Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
por: Gao, Yue, et al.
Publicado: (2023)

Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies
por: Yang, Richard K., et al.
Publicado: (2020)

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
por: Perrino, Matteo, et al.
Publicado: (2023)

Checkpoint inhibitors in hematological malignancies
por: Ok, Chi Young, et al.
Publicado: (2017)

Checkpoint inhibition in hematologic malignancies
por: Tsumura, Aaron, et al.
Publicado: (2023)

Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

Landscape of alterations in the checkpoint system in myelodysplastic syndrome and implications for prognosis
por: Moiseev, Ivan, et al.
Publicado: (2022)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

Mining novel biomarkers for prognosis of gastric cancer with serum proteomics
por: Qiu, Fu-Ming, et al.
Publicado: (2009)

Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review)
por: JIN, ZILIANG, et al.
Publicado: (2015)

Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction
por: Song, Ruixia, et al.
Publicado: (2023)

Isolation and Characterization of Extracellular Vesicles from Gastric Juice
por: Skryabin, Gleb O., et al.
Publicado: (2022)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Checkpoint inhibitors in the treatment of urological malignancies
por: Popovic, Lazar S, et al.
Publicado: (2017)

Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020)

SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
por: Chen, Shujia, et al.
Publicado: (2022)

Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
por: Ledda, Caterina, et al.
Publicado: (2018)

Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c35fckreuf8apd2kod9bkpt7jh